James C Hamilton insider trades

Open-market stock purchases and sales by James C Hamilton, Chief Medical Officer at Arrowhead Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 1, 2021.

Recent trades

DateStockTradeValue
Apr 23, 2026ARWR Arrowhead Pharmaceuticals, IncSold$750K
Mar 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$642K
Jan 6, 2026ARWR Arrowhead Pharmaceuticals, IncBought (not open market)—
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$379K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$932K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$813K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$21K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$283K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$77.4K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$28.8K

Companies traded

  • ARWR Arrowhead Pharmaceuticals, Inc: 55 sales, last Apr 23, 2026

Get free alerts when James C Hamilton files a new trade →